Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
12/20/2000 | EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor |
12/20/2000 | EP0830371B1 IMIDAZO(1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS |
12/20/2000 | EP0714295B1 Fibrinogen receptor antagonists |
12/20/2000 | EP0543858B1 Benzimidazole derivatives, process for their preparation and application |
12/20/2000 | CN1277556A Application of TNF antagonists as medicaments for treating septic diseases |
12/20/2000 | CN1277555A Composition for improving mental capabilities in mammals |
12/20/2000 | CN1277198A New bicyclo aminopyrazineone compound, its producing process and medical composition containing them |
12/20/2000 | CN1277197A Stable crystal salt of 5-methyl tetrahydrofolic acid |
12/20/2000 | CN1277053A Compound tree peony injecta |
12/20/2000 | CN1277034A Chinese medicine preparation |
12/20/2000 | CN1277022A Medical composition for treating thrombus and its use |
12/20/2000 | CN1059590C Medicine for blood generation and preparing method |
12/20/2000 | CN1059566C Method for preparing hemostatic |
12/19/2000 | US6162807 Thio acid derived monocyclic N-heterocyclics as anticoagulants |
12/19/2000 | US6162796 Method for transferring genes to the heart using AAV vectors |
12/19/2000 | US6162790 Oligopeptides |
12/19/2000 | US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease |
12/19/2000 | US6162427 Treating tumor by administering colony stimulating factor |
12/19/2000 | CA2189527C Novel elastase inhibitors |
12/14/2000 | WO2000075375A1 26 human secreted proteins |
12/14/2000 | WO2000075365A2 Compounds and methods to enhance raav transduction |
12/14/2000 | WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof |
12/14/2000 | WO2000075318A1 Phospholipid transfer protein |
12/14/2000 | WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof |
12/14/2000 | WO2000075275A2 Bioreactor design and process for engineering tissue from cells |
12/14/2000 | WO2000075186A1 Neuromedin b and somatostatin receptor agonists |
12/14/2000 | WO2000075172A2 FACTOR VIIa INHIBITORS |
12/14/2000 | WO2000075163A1 Angiogenic proteins and uses thereof |
12/14/2000 | WO2000075134A1 Pyrazinone thrombin inhibitors |
12/14/2000 | WO2000075129A1 Thiophene integrin inhibitors |
12/14/2000 | WO2000075107A2 Bradykinin receptor antagonists |
12/14/2000 | WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia |
12/14/2000 | WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
12/14/2000 | WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
12/14/2000 | WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY |
12/14/2000 | WO2000074713A1 Autologous thrombin |
12/14/2000 | WO2000074707A2 Use of interleukin-11 to treat hemorrhagic shock |
12/14/2000 | WO2000074701A2 Method and composition for inhibiting cardiovascular cell proliferation |
12/14/2000 | WO2000074695A2 Tanacetum parthenium extract |
12/14/2000 | WO2000074682A1 Thrombin inhibitors |
12/14/2000 | WO2000074681A1 Metalloprotease inhibitors |
12/14/2000 | WO2000074650A2 Implantable gel compositions and method of manufacture |
12/14/2000 | WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
12/14/2000 | WO2000046228A3 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
12/14/2000 | WO2000046225A3 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
12/14/2000 | WO2000043498A3 Human liver progenitors |
12/14/2000 | WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response |
12/14/2000 | WO2000029378A3 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
12/14/2000 | CA2383828A1 26 human secreted proteins |
12/14/2000 | CA2376506A1 Neuromedin b and somatostatin receptor agonists |
12/14/2000 | CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia |
12/14/2000 | CA2376400A1 Compounds and methods to enhance raav transduction |
12/14/2000 | CA2376358A1 Use of interleukin-11 to treat hemorrhagic shock |
12/14/2000 | CA2376335A1 Novel ig fractions having an immunomodulatory activity |
12/14/2000 | CA2376039A1 Bioreactor design and process for engineering tissue from cells |
12/14/2000 | CA2376018A1 Angiogenic proteins and uses thereof |
12/14/2000 | CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
12/14/2000 | CA2375882A1 Metalloprotease inhibitors |
12/14/2000 | CA2374654A1 Thrombin inhibitors |
12/14/2000 | CA2374558A1 Phospholipid transfer protein |
12/13/2000 | EP1059302A1 Factor VIIa inhibitors |
12/13/2000 | EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
12/13/2000 | EP1059088A1 New Ig-fractions with immunomodulation activity |
12/13/2000 | EP1059083A2 A solid pharmaceutical preparation for dialysis and a process for producing the same |
12/13/2000 | EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same |
12/13/2000 | EP1058549A1 THROMBIN OR FACTOR Xa INHIBITORS |
12/13/2000 | CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency |
12/13/2000 | CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv. |
12/12/2000 | US6160176 Anticoagulant agents |
12/12/2000 | US6160108 Platelet activation protein |
12/12/2000 | US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation |
12/12/2000 | US6160097 Regenerating active human polypeptides; freeze liquid containing human polypeptide, lipid and detergent, at a later time melt the liquid |
12/12/2000 | US6159964 Vitronectin receptor antagonists |
12/12/2000 | US6159468 Activated protein C formulations |
12/12/2000 | US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells |
12/11/2000 | CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
12/07/2000 | WO2000073478A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
12/07/2000 | WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
12/07/2000 | WO2000073451A1 Mammalian receptor proteins; related reagents and methods |
12/07/2000 | WO2000073450A2 Cytoskeleton-associated proteins |
12/07/2000 | WO2000073449A1 Dna encoding snorf33 receptor |
12/07/2000 | WO2000073443A1 Lipid metabolism transcription factor |
12/07/2000 | WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | WO2000073323A2 Adam polynucleotides and polypeptides |
12/07/2000 | WO2000073302A1 Oxazaheterocycles as protease inhibitors |
12/07/2000 | WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
12/07/2000 | WO2000073260A1 Squaric acid derivatives as cell adhesion molecules |
12/07/2000 | WO2000072882A1 Preventives for idiopathic thrombocytopenic purpura |
12/07/2000 | WO2000072845A1 Il-8 receptor antagonists |
12/07/2000 | WO2000072840A1 Il-8 receptor antagonists |
12/07/2000 | WO2000072815A1 Indole derivatives |
12/07/2000 | WO2000046224A3 Tricyclic pyridine n-oxides vasopressin agonists |
12/07/2000 | CA2375855A1 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | CA2375683A1 Il-8 receptor antagonists |
12/07/2000 | CA2375218A1 Squaric acid derivatives as cell adhesion molecules |
12/07/2000 | CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
12/07/2000 | CA2375047A1 Dna encoding snorf33 receptor |
12/07/2000 | CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity |
12/07/2000 | CA2374391A1 Mammalian receptor proteins; related reagents and methods |
12/07/2000 | CA2374376A1 Lipid metabolism transcription factor |